Neurology and Neurosurgery - Global Neurology Academy

17-32 of 481

Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiers
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
- Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
FA hiPSCs in Translational Drug Development
FA hiPSCs in Translational Drug Development
NeuroFrontiers
FA hiPSCs in Translational Drug Development
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
NeuroFrontiers
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
Proactive Pregnancy Planning and Reproductive Care in MS
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiers
Proactive Pregnancy Planning and Reproductive Care in MS
Riley Bove, MD, MMSc
- Riley Bove, MD, MMSc
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiers
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Aaron Miller, MD
- Aaron Miller, MD
Addressing Social and Systemic Barriers in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
Shelina Ramnarine, PhD; Margaret Emerson, DNP, APRN, PMHNP-BC
- Shelina Ramnarine, PhD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Advancing Pediatric MS Care: Insights from AAN 2026
Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiers
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
- Elizabeth Wilson, MD
Depression as a Signal of MS Progression
Depression as a Signal of MS Progression
NeuroFrontiers
Depression as a Signal of MS Progression
Challenging the Status Quo in Schizophrenia Treatment
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of Schizophrenia
Challenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD; Stephen Marder, MD
- Shelina Ramnarine, PhD
- Stephen Marder, MD
The Social Brain in Schizophrenia
The Social Brain in Schizophrenia
On the Frontlines of Schizophrenia
The Social Brain in Schizophrenia
Shelina Ramnarine, PhD; Michael Green, PhD
- Shelina Ramnarine, PhD
- Michael Green, PhD
Updates in MS Care: Key Topics at AAN 2026
Updates in MS Care: Key Topics at AAN 2026
NeuroFrontiers
Updates in MS Care: Key Topics at AAN 2026
Aaron Miller, MD
- Aaron Miller, MD
Emerging Serum microRNAs as Early Signals in MS
Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiers
Emerging Serum microRNAs as Early Signals in MS
Nutrition and the Gut-Brain Connection in Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
Shelina Ramnarine, PhD; Deanna L. Kelly, PharmD, BCPP
- Shelina Ramnarine, PhD
- Deanna L. Kelly, PharmD, BCPP
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
MinuteCE®
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
1.00 program credit
- Christyn Edmundson, MD
1.00 program credit
Family Planning in Patients with Multiple Sclerosis
Family Planning in Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning in Patients with Multiple Sclerosis
Strengthening Global Infrastructure for FSHD Trials
Strengthening Global Infrastructure for FSHD Trials
AudioAbstracts
Strengthening Global Infrastructure for FSHD Trials
Marlene Mimi Maeusli, PhD.
- Marlene Mimi Maeusli, PhD.

2/7